Skip to Content

Compumedics Ltd CMP

Morningstar Rating
A$0.27 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CMP is trading at a 47% discount.
Price
A$0.26
Fair Value
A$7.97
Uncertainty
Extreme
1-Star Price
A$1.49
5-Star Price
A$6.88
Economic Moat
Dtjm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CMP is a good fit for your portfolio.

Trading Information

Previous Close Price
A$0.27
Day Range
A$0.250.27
52-Week Range
A$0.140.45
Bid/Ask
A$0.25 / A$0.28
Market Cap
A$46.95 Mil
Volume/Avg
24,996 / 34,572

Key Statistics

Price/Earnings (Normalized)
20.03
Price/Sales
0.85
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Compumedics Ltd is a medical device company. It is engaged in the development, manufacture, and commercialisation of diagnostic technologies for sleep, brain and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of Americas, Australia and the Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
135

Valuation

Metric
CMP
Price/Earnings (Normalized)
20.03
Price/Book Value
2.60
Price/Sales
0.85
Price/Cash Flow
19.77
Price/Earnings
CMP

Financial Strength

Metric
CMP
Quick Ratio
0.69
Current Ratio
1.32
Interest Coverage
4.64
Quick Ratio
CMP

Profitability

Metric
CMP
Return on Assets (Normalized)
5.50%
Return on Equity (Normalized)
12.57%
Return on Invested Capital (Normalized)
10.17%
Return on Assets
CMP
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesTkrncmjcnDynnfm$188.9 Bil
SYK
Stryker CorpDrmqcnqbYhgy$129.0 Bil
MDT
Medtronic PLCQncqmqgysMjvsxz$106.5 Bil
BSX
Boston Scientific CorpBqxdnyhcGmykqj$100.9 Bil
EW
Edwards Lifesciences CorpHkhpqtlchZrhqdl$53.7 Bil
DXCM
DexCom IncFpztkyddpjGqtq$51.9 Bil
ZBH
Zimmer Biomet Holdings IncWsttykncbLphdw$25.5 Bil
ALGN
Align Technology IncFsptgwpKnnyg$24.7 Bil
PHG
Koninklijke Philips NV ADRSmbcrzznXnxrv$18.7 Bil
PODD
Insulet CorpSsdmldncdKgnwwq$12.3 Bil

Sponsor Center